SANTA MONICA, Calif., Aug. 06, 2021 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (BioVie or the Company), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders, liver disease and…
